Fibrosis in systemic sclerosis: common and unique pathobiology.
about
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisFibroblasts in fibrosis: novel roles and mediatorsGene expression profiling offers insights into the role of innate immune signaling in SScGenome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.Effectiveness of rosiglitazone in reducing flexion contracture in a rabbit model of arthrofibrosis with surgical capsular release: A biomechanical, histological, and genetic analysisThe effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseEmerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.The Role of PPAR Gamma in Systemic Sclerosis.Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process.Why target the tumor stroma in melanoma?Editorial: Bench to Bedside-and Back Again: Finding the Goldilocks Zone Within the Scleroderma Universe.Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
P2860
Q26781257-A279E27C-B30E-46BC-AFB5-52A1991E4390Q26998508-8E7CB43E-521D-4872-AE05-51DBDBBFEB14Q28083733-39DBEA0C-0CB3-46E5-8AA7-B3B1646B7208Q34475490-7224791E-DCD5-4CDE-A0EF-EE50AF315196Q35064030-49B48FCC-3DA9-46F8-A5B6-12B767BB1758Q36051223-C736B065-669B-4D93-9148-EE118D892139Q37227633-8B49EB05-3536-469A-9CDC-8F402400A99EQ38122314-7390793B-9155-412A-89F6-81A93C316779Q38202115-E029E759-C4D3-449C-B463-474F880D7C9EQ38325712-B4E120CA-066F-440D-B947-B978B2F85289Q38524619-DB8652AE-E745-4A52-8EE0-18BA42A9A2E9Q47109594-08B48C7E-2305-4191-A84F-164671B07F5FQ47282821-5ABAC9C7-45A0-4C9C-B869-08A954F717A6Q47645232-5B12B82F-01CB-4CCC-83FE-8BA7F74CE112Q50091398-F6C7CC4B-E98C-48C2-98F6-F98F83BE9A35Q57110619-90DA610F-31AD-4855-A4B1-BFA630E9EAD6
P2860
Fibrosis in systemic sclerosis: common and unique pathobiology.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Fibrosis in systemic sclerosis: common and unique pathobiology.
@ast
Fibrosis in systemic sclerosis: common and unique pathobiology.
@en
type
label
Fibrosis in systemic sclerosis: common and unique pathobiology.
@ast
Fibrosis in systemic sclerosis: common and unique pathobiology.
@en
prefLabel
Fibrosis in systemic sclerosis: common and unique pathobiology.
@ast
Fibrosis in systemic sclerosis: common and unique pathobiology.
@en
P2093
P2860
P1476
Fibrosis in systemic sclerosis: common and unique pathobiology.
@en
P2093
Cara G Gottardi
John Varga
Monique Hinchcliff
Swati Bhattacharyya
Warren G Tourtellotte
P2860
P2888
P356
10.1186/1755-1536-5-S1-S18
P433
P577
2012-06-06T00:00:00Z
P6179
1047427762